Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
G0.10 shRNA
- Development stage
- Preclinical
- Lead developer
- Inomagen Therapeutics
- Modality
- Viral-delivered RNAi → In Vivo RNAi → Gene Silencing → Gene Therapies, RNA Therapeutics → Nucleic Acid Therapeutics
- Administration
- Transvenous
01
Overview
G0.10 shRNA is an experimental gene therapy candidate being developed by Inomagen Therapeutics. It utilizes short hairpin RNA (shRNA) technology to target and knockdown the expression of the G0.10 gene. This candidate is part of Inomagen's early-stage research pipeline, which leverages their proprietary TRAVGE™ gene delivery platform. While the company's lead program is focused on NOX2 for the treatment of Atrial Fibrillation, G0.10 shRNA represents a secondary target within their cardiovascular and electrophysiological therapeutic portfolio. Specific clinical indications for G0.10 shRNA have not yet been publicly detailed, but it is being explored within the context of the company's focus on heart rhythm disorders.
- Other names
- G0.10 short hairpin RNAG-0.10 short hairpin RNAG 0.10 short hairpin RNA
Beyond the preview
Go deeper on G0.10 shRNA.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on G0.10 shRNA.